Immunohistochemical Expression of Endoplasmic Reticulum Stress Markers and their Association With Clinicopathological Characteristics and Survival Outcomes in Endometrial Cancer
Cancer Diagnosis & Prognosis · 01.03.2026 · 6 (2) · 322-334
DOI: 10.21873/cdp.10531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.03.2026. Verfasst von Stefanos Flindris und 18 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, School of Medicine, General Hospital of Thessaloniki "Ippokratio",…. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aim: This study aimed to examine the immunohistochemical expression of Inositol-Requiring Enzyme 1 Alpha (IRE1) and Protein Kinase R-like ER Kinase (PERK) immunoreactivity scores (IRS) as emerging biomarkers on key clinicopathologic features and survival outcomes in endometrial cancer (EC). Patients and Methods: Immunoreactive scores (IRS) for IRE1 and PERK were assessed in tumor samples from 73 EC survivors and compared with 20 benign endometrial controls. Associations between IRS values and clinicopathological variables were analyzed. Overall survival (OS) and disease-free survival (DFS) were evaluated using univariable and multivariable Cox proportional hazards models adjusted for age, FIGO stage, and tumor grade. Results: IRE1-IRS and PERK-IRS were significantly higher in EC survivors compared to controls (p=0.015 and p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 2nd Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, School of Medicine, General Hospital of Thessaloniki "Ippokratio", Thessaloniki, Greece.
- Department of Pathology, General Hospital of Thessaloniki "Ippokratio", Thessaloniki, Greece.
- Department of Hygiene and Epidemiology, University of Ioannina, School of Medicine, Ioannina, Greece.
- Department of Ophthalmology, General Hospital of Ioannina "G. Hatzikosta", Ioannina, Greece.
- Department of Radiology, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece.
- Department of Obstetrics and Gynecology, University Hospital of Ioannina, University of Ioannina, School of Medicine, Ioannina, Greece.
Zitieren
APA
Flindris, S., Margioula-Siarkou, C., Gouta, C., Christopoulos, K., Margioula-Siarkou, G., Almperi, E. A., Almperis, A., Traianos, A., Kalinderis, M., Sakellariou, E., Flindris, K., Karachalios, C., Styliara, E., Angelidou, S., Pantazis, K., Navrozoglou, I., Dinas, K., Markozannes, G., & Petousis, S. (2026). Immunohistochemical Expression of Endoplasmic Reticulum Stress Markers and their Association With Clinicopathological Characteristics and Survival Outcomes in Endometrial Cancer. Cancer Diagnosis & Prognosis, 6(2), 322-334. https://doi.org/10.21873/cdp.10531
Vancouver
Flindris S, Margioula-Siarkou C, Gouta C, Christopoulos K, Margioula-Siarkou G, Almperi EA, et al. Immunohistochemical Expression of Endoplasmic Reticulum Stress Markers and their Association With Clinicopathological Characteristics and Survival Outcomes in Endometrial Cancer. Cancer Diagnosis & Prognosis. 2026;6(2):322-334. doi:10.21873/cdp.10531
BibTeX
@article{Flindris2026,
author = {Flindris, Stefanos and Margioula-Siarkou, Chrysoula and Gouta, Chrysoula and Christopoulos, Konstantinos and Margioula-Siarkou, Georgia and Almperi, Emmanouela-Aliki and Almperis, Aristarchos and Traianos, Alexandros and Kalinderis, Michail and Sakellariou, Eleni and Flindris, Konstantinos and Karachalios, Charalampos and Styliara, Effrosyni and Angelidou, Stamatia and Pantazis, Konstantinos and Navrozoglou, Iordanis and Dinas, Konstantinos and Markozannes, Georgios and Petousis, Stamatios},
title = {Immunohistochemical Expression of Endoplasmic Reticulum Stress Markers and their Association With Clinicopathological Characteristics and Survival Outcomes in Endometrial Cancer},
journal = {Cancer Diagnosis & Prognosis},
year = {2026},
volume = {6},
number = {2},
pages = {322--334},
doi = {10.21873/cdp.10531}
}
EUVIMED